A Treatment Use Protocol for Subjects Continuing on From the Open-label Extension 0601

NCT01002820 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

11

Enrollment

INDUSTRY

Sponsor class

Conditions

Epilepsy, Complex Partial

Interventions

DRUG: ganaxolone

Sponsor

Marinus Pharmaceuticals